Showing results (111-120 of 186) with videos related to

Sort By:
Pageof 19
Oncology Reports|October 26, 2011
Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) studyDimitrios Pectasides, George Papaxoinis, Vassiliki Kotoula, et al.
Oncology|January 12, 2008
Evaluation of the prognostic and predictive value of HER-1/EGFR in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapyOlympia Tzaida, Helen Gogas, Urania Dafni, et al.
Urologic Oncology|August 30, 2022
Investigation of prognostic biomarkers in patients with urothelial carcinoma treated with platinum-based regimensKyriaki Papadopoulou, Georgia-Angeliki Koliou, Dimitrios Tsimiliotis, et al.
Targeted Oncology|November 30, 2018
Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Cancer. A Hellenic Cooperative Oncology Group Phase I/II StudyVasilios Karavasilis, Epaminontas Samantas, Georgia-Angeliki Koliou, et al.
Clinical Breast Cancer|May 22, 2012
Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expressionEvangelia Razis, Konstantine T Kalogeras, Vassiliki Kotoula, et al.
Anticancer Research|April 30, 2016
Interaction Between Beta-Catenin and EGFR Expression by Immunohistochemistry Identifies Prognostic Subgroups in Early High-risk Triple-negative Breast CancerSotirios Lakis, Stefanos Dimoudis, Vassiliki Kotoula, et al.
Breast Cancer Research and Treatment|June 28, 2005
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology GroupGeorge Fountzilas, Dimitrios Pectasides, Anna Kalogera-Fountzila, et al.
Anticancer Research|July 1, 2015
Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group TrialHelena Linardou, Konstantine T Kalogeras, Ralf Kronenwett, et al.
American Journal of Cancer Research|December 2, 2016
Disease evolution and heterogeneity in bilateral breast cancerElena Fountzilas, Vassiliki Kotoula, Flora Zagouri, et al.
Histology and Histopathology|March 26, 2015
Impact of tumor angiogenic profile on the outcome of patients with metastatic breast carcinoma treated with weekly docetaxel. A Hellenic Cooperative Oncology Group (HeCOG) studyHelen P Kourea, Vassiliki Kotoula, Angelos Koutras, et al.
Pageof 19